Traditional Chinese medicinal composition for curing osteoarthritis

Abstract

The invention provides a traditional Chinese medicinal composition for curing osteoarthritis and a preparation method thereof. The traditional Chinese medicinal composition is prepared from the following crude drugs, by weight, 10-20 parts of Poria cocos, 5-15 parts of polyporus, 5-15 parts of rhizoma alismatis, 5-15 parts of fried atractylodes, 5-15 parts of Plantain seed, 5-15 parts of artemisia capillaries, 3-9 parts of phellodendron, 5-15 parts of Radix Codonopsis, 5-15 parts of clematis root and 5-15 parts of seatung bark. The composition has functions of invigorating spleen, excreting dampness, clearing heat, alleviating water retention and activating meridians to stop pain. It is verified and proved through clinical tests that the traditional Chinese medicinal composition has significant effects of relieving pain and swelling symptoms of patients with osteoarthritis in the stage of attack, improving the function of the knees, raising life quality of patients and delaying progression of osteoarticular diseases such as osteoarthritis and the like. In addition, the traditional Chinese medicinal composition has little toxic and side effect, and costs are low.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating osteoarthritis. Background technique [0002] Osteoarthritis is a degenerative joint disease with the degeneration of articular cartilage as the core and related to aging in varying degrees. Investigations show that the incidence of osteoarthritis is worldwide distribution, the total prevalence of osteoarthritis at home and abroad is about 15%, 50% over the age of 60, and more than 80% of people over the age of 75 suffer from Osteoarthritis, the final disability rate of the disease is 53%, which seriously affects the quality of life of middle-aged and elderly people. The population over the age of 60 in my country has exceeded 100 million, and it is estimated that there are about 50 million patients with osteoarthritis, and the corresponding medical expenses are also on the rise year by year. [0003] Cartilage...

AI Technical Summary

Problems solved by technology

[0005] However, the inventor found in the research on the law of TCM syndromes of osteoarthritis in the past 10 years that the TCM syndromes in the remission period of osteoarthritis are mainly kidney deficiency, while the TCM syndromes in the attack period are mainly spleen deficiency and damp injection. However, there is currently a lack of effective drugs that have the functions of invigorating the spleen and expelling dampness, clearing away heat and diuresis, dredging collaterals and relieving pain, significantly relieving joint swelling, pain, and functional limitation in patients with osteoarthritis in the attack stage, improving the quality of life of patients, and delaying the progression of the disease.

Images